Find disease awareness content and relevant supporting materials

A novel treatment with intravenous levosimendan and vasopressin for new-onset acute pulmonary hypertension after weaning from cardiopulmonary bypass is described.

To date, data regarding the efficacy and safety of administering fibrinogen concentrate in cardiac surgery are limited. Studies are limited by their low sample size and large heterogeneity with regard to the patient population...

The assessment of pulmonary artery pressure (PAP) and parameters describing right ventricular function stand in the focus of the diagnosis...

The primary Efficacy Objective is to demonstrate that a single dose of V710 administered prior to cardiothoracic surgery will reduce...

Although previous studies have included early reexploration for bleeding as a risk factor in analyzing adverse outcomes after cardiac operations, reexploration for bleeding has not been systematically examined as...

Recently introduced in the treatment algorithms and guidelines for the treatment of ulcerative colitis, biological therapy is an effective treatment option for patients with an acute severe flare not responsive to conventional treatments and for patients with steroid dependent disease.

Pulmonary arterial hypertension is a disease characterised by pathological changes in the pulmonary arteries leading to a progressive increase in...

The 32nd Annual Congress of the European Association of Cardiothoracic Anaesthesiology (EACTA) is taking place this week (19-21 April 2017) in Berlin.

The primary goal of this study is to compare in the long-term costs of laparoscopic or open right colectomy in...